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Abstract 
Objective— 
We explored mechanisms that alter mitochondrial structure and function in pulmonary 
endothelial cells (PEC) function after hyperoxia. 
Approach and Results— 
Mitochondrial structures of PECs exposed to hyperoxia or normoxia were visualized and 
mitochondrial fragmentation quantified. Expression of pro-fission or fusion proteins or autophagy-
related proteins were assessed by Western blot. Mitochondrial oxidative state was determined using 
mito-roGFP. Tetramethylrhodamine methyl ester estimated mitochondrial polarization in treatment 
groups. The role of mitochondrially derived reactive oxygen species in mt-fragmentation was 
investigated with mito-TEMPOL and mitochondrial DNA (mtDNA) damage studied by using ENDO III 
(mt-tat-endonuclease III), a protein that repairs mDNA damage. Drp-1 (dynamin-related protein 1) was 
overexpressed or silenced to test the role of this protein in cell survival or transwell resistance. 
Hyperoxia increased fragmentation of PEC mitochondria in a time-dependent manner through 48 
hours of exposure. Hyperoxic PECs exhibited increased phosphorylation of Drp-1 (serine 616), 
decreases in Mfn1 (mitofusion protein 1), but increases in OPA-1 (optic atrophy 1). Pro-autophagy 
proteins p62 (LC3 adapter–binding protein SQSTM1/p62), PINK-1 (PTEN-induced putative kinase 1), 
and LC3B (microtubule-associated protein 1A/1B-light chain 3) were increased. Returning cells to 
normoxia for 24 hours reversed the increased mt-fragmentation and changes in expression of pro-
fission proteins. Hyperoxia-induced changes in mitochondrial structure or cell survival were mitigated 
by antioxidants mito-TEMPOL, Drp-1 silencing, or inhibition or protection by the mitochondrial 
endonuclease ENDO III. Hyperoxia induced oxidation and mitochondrial depolarization and impaired 
transwell resistance. Decrease in resistance was mitigated by mito-TEMPOL or ENDO III and 
reproduced by overexpression of Drp-1. 
Conclusions— 
Because hyperoxia evoked mt-fragmentation, cell survival and transwell resistance are 
prevented by ENDO III and mito-TEMPOL and Drp-1 silencing, and these data link hyperoxia-induced 





The potential of high fractions of oxygen to damage lungs of humans and experimental animals 
has been recognized for >35 years.1–3 Acute lung injury or Adult Respiratory Distress Syndrome is the 
leading cause for admission to nonsurgical intensive care units and complicates the course of >25% of 
patients admitted to intensive care units. Adult Respiratory Distress Syndrome is invariably treated 
with supplemental oxygen to sustain vital organ function and is life-saving in the short term. However, 
supplemental oxygen is injurious to the lungs, increasing pulmonary microvascular permeability within 
<24 hours.2 With movement of fluid into the alveolar spaces, gas exchange is impaired such that ever-
higher fractions of inhaled oxygen and higher airway pressures are required to maintain tissue 
oxygenation. Therefore, interventions that limit hyperoxia-associated pulmonary edema are highly 
desirable. 
Rats exposed to hyperoxia show increased death of pulmonary endothelial cells (PECs) in a 
time- and concentration-dependent manner.4 A central role for mitochondria in hyperoxic-induced PEC 
death is supported by previous reports of increased reactive oxygen species (ROS), decreased ATP 
production, and reduced respiratory chain activity in the lungs of rodents exposed to 
hyperoxia.3 However, the exact mechanisms by which hyperoxic exposure leads to PEC death are not 
well understood. 
One poorly defined connection is how mitochondrial ultrastructure contributes to hyperoxic 
injury. Mitochondria exist in a dynamic state with frequent mitochondrial fission and fusion in healthy 
cells.5–7 A balance between mitochondrial fission and fusion is paramount to properly functioning 
mitochondria.8,9 Shifts in endothelial or smooth muscle cell mito-fission contribute to endothelial cell 
injury in diabetes mellitus, atherosclerosis, hypertension, and pulmonary artery hypertension. But the 
effects of hyperoxia on mitochondrial structure in PECs are not known. Of the 40+ cell types in the 
lung, endothelial cells are among the most abundant and sensitive to hyperoxic injury, showing 
decreases in cell numbers as well as morphological changes before other indices of injury, including 
edema, neutrophilic influx, or hypoxemia. We examined mitochondrial structure and oxidative state 
using immunofluorescence and recombinant protein probes along with expression of genes that 
regulate mitochondrial shape in PECs exposed to hyperoxia. We also investigated the functional 
implications of hyperoxia on PEC survival, mitochondrial structure, and endothelial cell function. We 
find that hyperoxia induces mitochondrial fragmentation that correlates to both increased fission and 
decreased fusion protein expression to mitochondrially derived ROS and transendothelial electric 
resistance (TEER). Our detailed findings of hyperoxia-induced mitochondrial fragmentation in PECs 
afford potentially novel therapeutic targets. 
Materials and Methods 
Materials and Methods are available in the online-only Data Supplement. 
Results 
We obtained transmission electron microscopy of endothelial cells in pulmonary arteries from 
rats treated in vivo to normoxic (21% O2) or hyperoxic (>95% O2) exposures for 48 hours (Figure 1). 
Hyperoxia caused scattered separation of the endothelium from the basement membrane, but the 
basement membranes appeared generally intact. Widespread loss in mitochondrial ultrastructure 
occurred with cristae disrupted and diminished. 
 
Figure 1. Transmission electron micrographs at 2 magnifications show structural changes in pulmonary artery endothelial 
cells of rats exposed for 48 hours to normoxia or hyperoxia in vivo. Lower power studies demonstrated scattered 
separation of pulmonary endothelial cell (PECs; identified with red asterix and “EC”) from underlying basement membrane 
in hyperoxia samples but not normoxic ones. At higher power, the mitochondrial cristae are visible in cells maintained in 
normoxia but are disrupted or absent in hyperoxic specimens (see red arrows with “mito” label). EC indicates endothelial 
cell. 
 
To examine the effect of hyperoxia on the structure of mitochondria in cultured PECs, we used 
either a fluorescently tagged antibody to the TOM20 (translocase of outer membrane receptor 
complex, Figure 2) or mitochondrially targeted roGFP (data not shown). Mitochondrial fragmentation 
index (MFI), a quantification of the noncontiguous (fragmented) mitochondria, increased as early as 6 
hours after hyperoxia and further over 48 hours. 
 
 
Figure 2. Pulmonary endothelial cells (PECs) were cultured in normoxia or hyperoxia for 6 through 48 hours. Mitochondria 
were visualized with a fluorescent antibody to the translocase of outer membrane (TOM-20) receptor complex. 
Representative images as well as a graph of averaged mitochondrial fragmentation indices (n=6 random cells from at least 3 
isolations for each time point, 20 total from each time point) are shown. The number of noncontiguous mitochondrial 
fragments and the number of pixels in the mitochondria were identified by ImageJ. The mitochondrial fragmentation index 
(MFI) was calculated by dividing the number of noncontiguous fragments by the number of pixels and multiplying the result 
by 1000. Data were normally distributed with equal variance and compared by analysis of variance (ANOVA). *P<0.05; 
**P<0.01, different from normoxia; #P<0.05, different from 6 and 12 hours hyperoxia. 
We next assessed time-dependent changes in pro-fission or fusion proteins. PECs exhibit 
increases in the pro-fission phosphorylated Drp-1 (dynamin-related protein 1) as early as 6 hours after 
exposure to hyperoxia, increases which are gone by 24 hours (Figure 3A). In contrast, total Drp-1 rises 
over 48 hours such that the ratio of serine 616 phospho-Drp-1 to Drp-1 is increased 6 through 12 hours 
after hyperoxia, but decreases thereafter to baseline values. Mfn1 (mitofusion protein 1) decreases by 
48 hours after hyperoxia (Figure 3B). OPA-1 (optic atrophy 1), a profusion protein, is increased after 48 
hours (Figure 3C). 
 
 
Figure 3. A, Representative and averaged data from Western blots of pulmonary endothelial cells (PECs) exposed in culture 
to hyperoxia for periods of time as appearing on the x axis and probed with a primary antibody for phosphorylated Drp-1 
(dynamin-related protein 1), total Drp-1, or β-actin. N=6 for each bar in both graphs. Phosphorylated Drp1 relative to total 
Drp1 was increased at 6 and 12 hours after exposure to hyperoxia, then decreased back to baseline values thereafter. In 
contrast, total Drp-1 increased after 24 hours relative to β-actin and remained elevated through 48 hours, demonstrating 2 
levels of regulation. Data were normally distributed with equal variance and compared by analysis of variance (ANOVA). 
*P<0.05, different from normoxia controls. B, Representative images of Western blots and averaged data show that Mfn1 
(mitofusion protein 1) density decreased by 48 hours. N=6 endothelial cell isolates for each time point. Data were not 
normally distributed with equal variance and compared by ANOVA on Ranks. *P<0.05, different from normoxia controls. C, 
Representative and averaged data show that OPA-1 (optic atrophy 1) density relative to that of β-actin is increased in PECs 
exposed for 48 hours to hyperoxia (n=7 each for normoxia and hyperoxia). Data were normally distributed with equal 
variance and compared by ANOVA with Dunnett’s. *P<0.03, different from normoxia. 
Because hyperoxia is reported to activate apoptosis and autophagy,4,10 we also examined 
caspase 3/7 activity and expression of LC3B (microtubule-associated protein 1A/1B-light chain 3), p62 
(LC3 adapter–binding protein SQSTM1/p62), and PINK-1 (PTEN-induced putative kinase 1) in PECs. 
Apoptosis as quantified by caspase 3/7 activity in PECs maintained in normoxia or hyperoxia was low 
but increased by ≈1.8-fold (1.2±0.2% versus 2.2±0.1%; n=8; P<0.01) with hyperoxia. LC3B expression 
increased in PECs exposed to hyperoxia relative to that of counterparts cultured in normoxia (Figure 
4A). PINK-1 expression was decreased by hyperoxia, consistent with increased Drp-1 or defective 
parkin localization to damaged mitochondria, and impaired autophagy (Figure 4B).11 Ubiquitin-binding 
protein p62 increased in a time-dependent manner in hyperoxic PECs, as well as in whole lung 
homogenates of rat lungs exposed in vivo to hyperoxia (Figure 4C and 4D). 
 
 
Figure 4. A, Representative and averaged data for normoxia and 48 hours show that LC3B (microtubule-associated protein 
1A/1B-light chain 3) 1/2 density relative to that of β-actin is increased by hyperoxia. N≥4 for each time point in graph. Data 
were normally distributed with equal variance and compared by t test. *P<0.01, different from normoxia. B, Representative 
and averaged data show that PINK-1 (PTEN-induced putative kinase 1) density relative to that of β-actin is decreased in 
pulmonary endothelial cells (PECs) exposed for 48 hours to hyperoxia (n=7 each for normoxia and hyperoxia). Data were 
normally distributed with equal variance and compared by t test. *P<0.005, different from normoxia. C, Representative 
Western blots and averaged band intensity showing p62 density normalized to β-actin in PECs. N=6 endothelial cell isolates 
for each time point. p62 (LC3 adapter–binding protein SQSTM1/p62) density increased after 24 hours and remained 
elevated through 48 hours. Data were normally distributed with equal variance and compared by analysis of variance 
(ANOVA). *P<0.05, different from normoxia. D, Representative and averaged data show that p62 density relative to that of 
β-actin is increased in whole lung homogenates by 48 hours exposure of rats in vivo to hyperoxia (n=9 each for normoxia 
and hyperoxia). Data were normally distributed with equal variance and compared by t test. *P<0.001, different from 
normoxia. 
To investigate the role of mitochondrial ROS in enhanced mitochondrial fragmentation, we 
used mitochondrially targeted superoxide indicator (mito-SOX) and mito-TEMPOL (mitochondria-
targeting superoxide dismutase mimetic). Mito-SOX fluorescence increased by 48 hours of hyperoxia 
exposure; treatment with mito-TEMPOL or TEMPOL (Figure 5A) blocked the increase in mito-SOX. 
 
 
Figure 5. A, Representative and averaged values of mitochondrially targeted superoxide indicator (mito-SOX) fluorescence. 
Hyperoxia-induced increments in fluorescence of mito-SOX were blocked by TEMPOL and mito-TEMPOL (n=6 representative 
fields for each condition, from 3 separate experiments). Data failed normality tests and were compared by analysis of 
variance (ANOVA) on Ranks. *P<0.05, different from normoxia, ##P<0.01, different from hyperoxia. B, Representative high 
resolution images of pulmonary endothelial cells (PECs) exposed to normoxia (control) hyperoxia for 48 hours, 
hyperoxia+mito-TEMPOL for 48 hours, or hyperoxia+ENDO III (mt-tat-endonuclease III) for 48 hours. Cells were imaged live 
with Mito-Tracker staining. Insets show gray scale, higher magnification images with regions of interest (ROI) indicated in 
the full cell images to show increase in fragmentation by hyperoxia and improvement by mito-TEMPOL and ENDO-III. 
Mitochondrial fragmentation index (MFIs) calculated from whole cell ROIs appear under the legends that identify 
treatment. These data demonstrate increased mitochondrial fragmentation with hyperoxia and protection with either mito-
TEMPOL or ENDO-III. C, “Nor” cells were treated with vehicle for tempol, mito-tempol, or ENDO III (mt-tat-endonuclease 
III). MFIs were measured in images of cells exposed to normoxia or hyperoxia 48 hours later. Hyperoxia-induced increases in 
MFI are blocked by both TEMPOL and mito-TEMPOL, as well as 0.1 μg mt-tat-ENDO III (n=20 cells from each group). Data 
were normally distributed with equal variance and compared by ANOVA. *P<0.01, different from normoxia, #P<0.01, 
different from hyperoxia. D, PECs were exposed to normoxia or hyperoxia for 48 hours. Inclusion of mito-TEMPOL but not 
TEMPOL(10 μm each) prevented the increase in ratio of total Drp1 to actin. Data were normally distributed with equal 
variance and compared by ANOVA. **P<0.01 different from normoxia; *P<0.05 different from hyperoxia and 
hyperoxia+TEMPOL. N=11, 11, 4, and 4 endothelial cell isolates. 
To identify a connection between mt-ROS, mt-fragmentation, and mitochondrial DNA damage, 
we measured MFIs in cells incubated for 48 hours in normoxia or hyperoxia with tempol, mito-
TEMPOL, or ENDO III (mt-tat-endonuclease III). Figure 5Bshows images of mitochondria in 
representative cells cultured in normoxia, hyperoxia, hyperoxia with mito-TEMPOL, or hyperoxia with 
ENDO III. Figure 5C shows that both TEMPOL and mito-TEMPOL (10 μm each) diminished hyperoxia-
induced increments in MFI. Similarly, the mitochondrial DNA repair protein ENDO III, blunted 
hyperoxia-induced increases in MFI. Mito-TEMPOL but not TEMPOL blocked hyperoxia-induced 
increments in Drp-1 expression by 48 hours (Figure 5D). 
We next examined time-dependent changes in the oxidative state of PECs to correlate these 
changes to mitochondrial fragmentation. We observed an increase in oxidation (defined by an increase 
in the ratio of roGFP fluorescence at 405/485) by 24 hours, a shift which was sustained but not further 
increased by 48 hours (Figure 6A). TEMPOL or mito-TEMPOL prevented the oxidative shift by hyperoxia 
(Figure 6B). These data tie an increase in PEC oxidation with hyperoxia to mitochondrial ROS, though 
we cannot entirely exclude the possibility of a nonmitochondrial ROS contribution given the relatively 
high dose of mito-TEMPOL and similar effects of TEMPOL on this end point. 
 
 
Figure 6. A, We studied the oxidative status of cells infected with ro-GFP lentivirus based on the ratio of fluorescence at 
405/488 nm. Oxidation was increased by 24 hours and remained elevated through 48 hours (n=5, 5, and 8 representative 
fields from 3 separate experiments for 0, 24, and 48 hours, respectively). Data were not normally distributed and compared 
by analysis of variance (ANOVA) on Ranks. **P<0.01, different from normoxia. B, Inclusion of TEMPOL or mito-TEMPOL (10 
mmol/L each) in incubation media for 48 hours during hyperoxia prevented the increase in oxidation as quantified by the 
ro-GFP fluorescence ratio 405/488. N=5 fields/condition, from 3 separate experiments. Data were not normally distributed 
and compared by ANOVA on Ranks. *P<0.05; ##P<0.01, different from hyperoxia. C, After incubation for 48 hours in 
normoxia or hypoxia, pulmonary endothelial cell (PECs) were washed with PBS, then loaded with a final concentration of 
100 nmol/L tetramethylrhodamine methyl ester (TMRM). TMRM fluorescence in images of cells from hyperoxic and 
normoxic environments were compared to assess for relative mitochondrial polarization. N=9 representative fields each 
from normoxic and hyperoxic cells from 2 separate isolations. Data passed normality and equal variance tests and were 
compared by ANOVA. *P<0.001 relative to normoxia. 
Because increased mitochondrial fragmentation may be associated with mitochondrial 
depolarization, we assessed the effect of hyperoxia on mitochondrial polarization in cultured PECs that 
exhibit mt-fragmentation. Using tetramethylrhodamine methyl ester (100 nmol/L), we identified 
decreased uptake of dye consistent with mitochondrial membrane depolarization by 48 hours 
hyperoxia, a time when these cells exhibit mt-fragmentation (Figure 6C). 
We next examined reversibility of changes in mitochondrial fragmentation, pro-fission, and pro-
fission/fusion protein expression. Return to normoxia for 24 hours after 48-hour exposure to hyperoxia 
reversed hyperoxia-induced changes in mito-SOX and MFI (Figure 7A and 7B, respectively). Increases in 
Drp-1 evoked by 48-hour hyperoxia were also reversed by 24 hours return to normoxia, strengthening 
the association between changes in mitochondrial fragmentation and these proteins (Figure 7C). 
Oxidative changes in PECs (Figure 7C) were likewise reversed within 24 hours return to normoxia. 
 
 
Figure 7. A, Mitochondrially targeted superoxide indicator (mito-SOX) fluorescence, which is increased 48 hours after 
hyperoxia, then decreases after 24 hours in normoxia (n=6 representative fields of cells for each condition, from 3 separate 
experiments). Data passed normality and equal variance tests and were compared by analysis of variance (ANOVA). 
*P<0.05, different from normoxia; **P<0.01, different from normoxia, ##P<0.01, different from hyperoxia. B, Averaged 
mitochondrial fragmentation index (MFI) show that increased mitochondrial fragmentation is resolved after 24 hours back 
in normoxia (N=18, 11, and 17 cells from 3 experiments). Data passed normality and equal variance tests and were 
compared by ANOVA. **P<0.01, different from normoxia, ##P<0.01, different from hyperoxia. C, Representative and 
averaged data show that Drp-1 (dynamin-related protein 1) density relative to that of β-actin is increased by 48 hours 
hyperoxia but recovered to baseline within 24 hours in normoxia (n=11 for each condition). Data were not normally 
distributed and compared by ANOVA on Ranks. **P<0.01, different from normoxia, #P<0.05; #P<0.01, different from 
hyperoxia. D, Oxidative status of cells infected with roGFP based on the ratio of fluorescence at 405/488 nm is increased by 
48 hours hyperoxia (Hyp) and partially recovered after 24 hours back in normoxia (Hyp+R). N=5 to 8 fields/condition, from 3 
separate experiments. Data failed equal variance test and were compared by ANOVA on Ranks. *P<0.01 relative to 
normoxia. 
To test the role of Drp-1 activation on the survival of cells, we measured the effect of hyperoxia, 
the Drp-1 inhibitor mitochondrial division mitophagy inhibitor (mDIVI), or siRNA to Drp-1 on 
incorporation of MTT. MTT incorporation was decreased by 24 hours hyperoxia and more densely so 
by 48 hours (Figure 8A). mDIVI (1 μmol/L) decreased MTT incorporation in normoxic PECs, but 
increased it in hyperoxic cells (Figure 8B), consistent with the interpretation that activation of Drp-1 
and pro-fission evoked by hyperoxia impair mitochondrial function and cell survival. siRNA to Drp-1 
had no effect on MTT incorporation in normoxic cells, consistent with low expression of this protein in 
healthy cells. However, MTT incorporation in hyperoxic cells was enhanced by Drp-1 siRNA (and not 
nonsense siRNA). Together, these data suggest hyperoxia-evoked increases in Drp-1 decrease cell 




Figure 8. A, MTT was measured in pulmonary endothelial cell (PECs) exposed to hyperoxia or normoxia for 24 or 48 hours 
(n=7 sets for 24 hours and n=8 sets for 48 hours each). Values were normalized to concomitant normoxia controls. 
Hyperoxia decreased MTT incorporation by 24 hours, and the decrease was greater by 48 hours. B, In cells treated for 48 
hours with the Dpr-1 (dynamin-related protein 1) inhibitor mitochondrial division mitophagy inhibitor (mDIVI; 1 μM final 
concentration), MTT uptake decreased under normoxic conditions, but increased MTT uptake after 48 hours hyperoxia. To 
further test the role of Drp-1 in cell survival, we treated rat PECs with nonsense (NS) siRNA or siRNA directed against Drp-1. 
These data are normalized to normoxic NS siRNA treated cells. Drp-1 directed siRNA protected from hyperoxia-linked 
decrease in MTT. Together, these data show improved survival by limiting expression of pro-fission Drp-1 in hyperoxia-
treated cells (n=6 sets except n=4 for siRNA experiments. MTT data for Figures 8A and 8B were normally distributed with 
equal variance and compared by analysis of variance (ANOVA). #P<0.01 relative to hyperoxia; *P<0.05 relative to normoxia; 
**P<0.01 relative to normoxia. C, These data show that rat PECs treated with nonsense control siRNA and lipofectamine 
exhibited a modest and insignificant decrease in Drp-1 protein expression over that of parallel control cells (≈15%). In 
contrast, the decrease in Drp-1 expression with siRNA directed to Drp-1 was to ≈65% that of control cells. N=4 groups of 
cells for each group. Data were normally distributed with equal variance and compared by ANOVA followed by Dunnett’s. 
*P<0.05. D, All data represent MTT in cells studied after 48 hours in normoxia or hyperoxia with vehicle or drugs/conditions 
per the x axis. Mito-TEMPOL did not change viability of cells in normoxia, but increased survival of cells in hyperoxia (n=6 
for each condition). Return of PECs to normoxia for 24 hours after 48 hours in hyperoxia results in recovery of MTT to 
baseline normoxia values (Hyper+R). mt-tat-ENDO III (mt-tat-endonuclease III; 0.1 μg/mL), which repairs mtDNA damage, 
has no effect on MTT in control (normoxic) cells, but affords protection from hyperoxia such that viability is increased over 
that of cells cultured in normoxia. (n=6 for each condition). Data were normally distributed with equal variance and 
compared by ANOVA. *P<0.05, different from normoxia, #P<0.05, different from hyperoxia. E, MTT was measured in PECs 
exposed to hyperoxia or normoxia for 48 hours (n=6 each) in cells treated with vehicle or the autophagy inhibitor 
bafilomycin (BFA; 10 nmol/L final concentration). Under normoxic conditions, BFA decreased MTT uptake modestly. In 
contrast, no change in MTT uptake was observed in hyperoxic cells treated with BFA. Data were normally distributed with 
equal variance and compared by ANOVA. #P<0.05 relative to normoxia. *P<0.01 relative to normoxia or normoxia+BFA. F, 
LDH (lactate dehydrogenase) is increased modestly (to 114% normoxia) in PECs exposed for 48 hours to hyperoxia relative 
to normoxia (n=6 each for normoxia and hyperoxia *P<0.003, different from normoxia). MTT assays in the same subset of 
cells was performed and is shown to the right. The latter data are consistent with MTT assays for other groups of hyperoxic 
cells. Both sets of data were normally distributed with equal variance and compared by t tests. 
To investigate a correlation between cell survival, mitochondrial ROS, and mt-DNA damage, we 
utilized mito-TEMPOL and ENDO III, a peptide which contains a mitochondrial localization sequence 
and endonuclease III to facilitate repair of mitochondrial DNA.12 Mito-TEMPOL restored MTT 
incorporation in hyperoxic cells to that of their normoxic counterparts. Mitochondrially targeted ENDO 
III peptide had no effect on MTT under normoxia (Figure 8D), but cell survival in hyperoxic PECs treated 
with ENDO III was greater than that of vehicle controls. These data directly link inhibition of 
mitochondrial ROS and mitochondrial DNA repair to cell survival in hyperoxia. 
We tested the role of autophagy in survival/mitochondrial function assays (MTT) of cells 
exposed to normoxia or hyperoxia for 48 hours using the autophagy inhibitor bafilomycin. Bafilomycin 
decreased MTT uptake in normoxia PECs but had no effect on that of hyperoxic cells (Figure 8E). 
To assess the viability/injury of cells in an assay independent of MTT incorporation (which is 
most closely linked to mitochondrial function), we measured LDH (lactate dehydrogenase) 
release. Figure 8F shows that LDH is increased modestly but significantly (to 114% normoxia values) in 
PECs exposed to hyperoxia for 48 hours, and these numbers in cells with MTT incorporation reduced to 
<60% normoxia values. 
Our subsequent series of experiments were focused on the functional status of PECs under 
conditions which evoked hyperoxia-induced changes in mitochondrial structure. First we quantified NO 
production as reflected by nitrite measurements in the media of cells exposed to normoxia or 
hyperoxia for 48 hours.13 Nitrites were low in control cells and increased by hyperoxia in a manner 
which was nearly completely inhibited by NOS inhibitor l-NAME (l-nitro-arginine methyl ester). ENDO III 
tended to increase nitrites in normoxic PECs and increased NO release over that of normoxic cells 
treated with this peptide in hyperoxic PECs (Figure 9A). NO levels in hyperoxic cells treated with mDIVI 
were not different from those of normoxia values. Consistent with hyperoxic increases in NO 
formation, eNOS (endothelial nitric oxide synthase) expression was increased (Figure 9B). 
 
Figure 9. A, We quantified NO production as reflected by nitrite in the media of pulmonary endothelial cells (PECs) exposed 
to normoxia or hyperoxia for 48 hours. Nitrites were low in control cells and significantly increased by hyperoxia in a 
manner which was nearly completely inhibited by NOS inhibitor L-NAME (L-nitro-arginine methyl ester). ENDO III (mt-tat-
endonuclease III) increased nitrites in hyperoxic PECs over that of normoxic counterparts, whereas mitochondrial division 
mitophagy inhibitor (mDIVI) blocked hyperoxia-induced increases in NO. n=4 to 5 for each group. Data were not normally 
distributed with normal variance and were compared by analysis of variance (ANOVA) on Ranks. *P<0.05 relative to 
normoxia. #P<0.05 vs Hyper. B, Consistent with hyperoxic increases in NO formation, eNOS (endothelial nitric oxide 
synthase) expression was increased in PECs by hyperoxia (n=7 each normoxia and hyperoxia). *P<0.05 relative to normoxia. 
Data were normally distributed with equal variance and compared by t test. 
 
We measured transwell resistance in PEC monolayers exposed in culture to normoxia or 
hyperoxia for 48 hours. Monolayer resistance was decreased by hyperoxia but not different from 
normoxia in hyperoxic PEC monolayers cultured with mito-TEMPOL or ENDO III in the media, data 
which link mtROS and mtDNA damage to barrier function in PECs (Figure 10A). Overexpression of Drp-1 
diminished TEER in normoxic monolayers but had no further effect on monolayer resistance in 
hyperoxic cells (Figure 10A), consistent with a deleterious effect of Drp-1 on TEER. Figure 10B shows 
that Drp-1 expression was increased >4-fold in our PECs transfected with Drp-1. 
 
 
Figure 10. A, We measured transwell resistance in pulmonary endothelial cell (PEC) monolayers exposed for 48 hours to 
normoxia or hyperoxia and treated with mito-Tempol (10 μmol/L) ENDO III (mt-tat-endonuclease III) (0.1 µg/mL) or with 
overexpression of Drp-1 (dynamin-related protein 1). Resistance was normalized to that of normoxia with vehicle or, in the 
case of Drp-1 overexpression, to monolayers treated with plasmids to overexpress Cherry (to visually identify transfection). 
Resistance is decreased by hyperoxia and by overexpression of Drp-1 in normoxia. Hyperoxic monolayers treated with mito-
TEMPOL or ENDO-III are protected from decreases in monolayer resistance. Overexpression of Drp-1 in hyperoxic 
monolayers does not change resistance over that of hyperoxia alone. Data passed normality and equal variance tests and 
were compared by analysis of variance (ANOVA). *P<0.05 relative to normoxia. #P<0.05 relative to hyperoxia vehicle. N=8 
transwells per condition. B, Western blots of PEC lysates were probed with primary antibodies for Drp-1 or phospho-Drp-1 
48 hours after transfection with no DNA, Cherry (control which permits visualization of cells overexpressing plasmid DNA) 
or Drp-1. Representative images are shown above. A graph demonstrating average increase in Drp-1 blot density is shown 
below (n=4). Transfection increases Drp-1 protein expression by >4-fold. Data were normally distributed with equal 
variance and compared by t test. *P<0.05. 
 
Finally, we performed 3 additional functional tests of PEC function after hyperoxia, which relate 
to recovery from acute lung injury. A scratch test (measures the capacity of endothelial cells to repair a 
gap) identified delayed migration by hyperoxia (Figure 11A), which is reversed by TEMPOL or mito-
TEMPOL in the media. Transwell migration of PECs (index of the capacity of endothelial cells for tissue 
invasion) is decreased by hyperoxia (Figure 11B), which is reversed by mito-TEMPOL but not TEMPOL. 
Networks in a 3-dimensional matrix are needed for angiogenesis (Figure 11C). Hyperoxia decreased the 
length of network formation of PECs in matrigel. Either mito-TEMPOL or TEMPOL protected against 
hyperoxia-evoked decreases in PEC network formation. 
 
Figure 11. A, Hyperoxia decreased migration of cells into a path cleared by a scratch relative to counterparts maintained in 
normoxia. TEMPOL or mito-TEMPOL partially restored diminished migration of pulmonary endothelial cells (PECs) in 
hyperoxia by 48 hours. Data were not normally distributed and were compared by analysis of variance (ANOVA) on Ranks. 
*P<0.05, different from normoxia; #P<0.05, different from hyperoxia; ##P<0.01, different from hyperoxia. n=12 
experiments for each condition and time. B, Transwell migration of PECs was compared in normoxia and hyperoxic 
conditions with 4 separate isolates of endothelial cells. Forty-eight hours hyperoxia decreased migration. Mito-TEMPOL but 
not TEMPOL restored migration to supra-normoxia values (n=29, 29, 23, and 22 wells, respectively, for each of the above 4 
groups from 4 separate experiments). Data were normally distributed with equal variance and compared by ANOVA 
followed by Dunnett’s. *P<0.05, different from normoxia, ##P<0.01, different from hyperoxia. C, Network formation of PECs 
in a 3-dimensional matrix is decreased by 24 hours hyperoxia. Both TEMPOL and mito-TEMPOL restore network formation 
(n=17–21 fields/condition, from 4 separate experiments). Data were normally distributed with equal variance and 
compared by ANOVA followed by Dunnett’s. *P<0.05, different from normoxia; #P<0.05 and ##P<0.01 different from 
hyperoxia. 
Discussion 
We demonstrate for the first time that PECs exposed to hyperoxia exhibit an increase in 
mitochondrial fragmentation. Changes occur within 6 hours of hyperoxia exposure and are mitigated 
by mito-TEMPOL or TEMPOL and are reversed within 24 hours of return to normoxia. Increases in 
phosphorylation of Drp-1, followed by an increase in total Drp-1 expression, as well as decreases in 
Mfn1 were observed, changes which promote mitochondrial fragmentation in other injury systems. On 
the other hand, hyperoxia also increases OPA-1 expression, an increase which we postulate may serve 
as a compensatory mechanism to limit mitochondrial fragmentation. 
 
Hyperoxia-induced mt-fragmentation correlates with diminished MTT (an index of cell survival 
or mitochondrial function) and elevated LDH but also increased NO synthesis and eNOS expression. 
MTT incorporation improves with mito-TEMPOL, the Drp-1 inhibitor m-DIVI or siRNA to Drp-1, and the 
mitochondrial endonuclease ENDO III, linking increased mitochondrial ROS, Drp-1 activation, and mt-
DNA damage, respectively, to changes in cell viability after hyperoxia. Mito-TEMPOL also prevents 
increases in Drp-1 expression, supporting a role for mt-ROS in shifting the balance to expression of 
mitochondrial fission proteins. Finally, increases in p62 and LC3B expression and decreases in PINK-1 
suggest activation of autophagy/mitophagy in this injury model. 
 
Mitochondrial redox states monitored by roGFP support increased oxidation, consistent with 
the increase in mitochondrial ROS (Figure 6B) and mitochondrial membrane depolarization (Figure 6C). 
Direct repair of mitochondrial DNA damage during hyperoxia, by addition of ENDO III, also improves 
cell survival as well diminishes mt-fragmentation. Hyperoxic changes in mitochondrial structure are 
accompanied not only by diminished cell survival but also by disruption of PEC function, including 
diminished monolayer resistance, gap closing, cell migration, and network formation in a 3-
dimensional matrix. These functional changes are also prevented by mito-TEMPOL, supporting cause 
and effect for mitochondrial ROS-driven mitochondrial fission, and PEC dysfunction, like increased ROS 
and mitochondrial fragmentation in endothelial cells exposed to hyperglycemia. TEER is diminished by 
Drp-1 overexpression in normoxia, consistent with a deleterious effect of Drp-1 on endothelial 
junctions, and protected by ENDO III in hyperoxic lungs. Our observations support a relationship 
between mitochondrial DNA injury and barrier integrity in rodent lungs, as has been suggested in 
glucose–glucose oxidase perfused isolated lungs,14 ischemia-reperfusion injury,15 or pseudomonas 
sepsis.16 Efficacy of ENDO III is also consistent with the enhanced sensitivity of mitochondrial DNA to 
oxidative injury relative to nuclear DNA.17 Our graphic abstract schematically summarizes a proposed 
pathway through which hyperoxia initiates mitochondrial fragmentation, as well as cellular dysfunction 
in PECs based on our data. 
The endothelium is an important target of lungs exposed to hyperoxia.1 Ahmad et al18 reported 
increases in the number of detached or necrotic cultured human lung microvascular endothelial cells 
exposed to hyperoxia versus normoxia, as well as mitochondrial cristae which appeared swollen. 
Others reported decreased DNA and protein synthesis, with diminished fluidity of the plasma 
membrane also resulting in decreased survival.19,20More importantly, survival was decreased in 
response to hyperoxia in endothelial cells exposed in vivo.18,21 We have identified a time- and 
concentration-dependent increase in PEC death in the lungs of rats exposed in vivo to 
hyperoxia.4,22 Our new data support increased caspase 3/7 activity in PECs to hyperoxia in culture. 
Augmented ROS production in the lungs of rodents exposed to hyperoxia have been well 
documented.3,23 NADPH oxidase 2 and 4 (NOX2 and NOX4) expression are increased in human lung 
microvascular endothelial cells exposed to hyperoxia and contribute to hyperoxia-evoked ROS by 
multiple pathways.24–26ATP and activities of complex I and II are decreased in the lungs of hyperoxia-
exposed rats.27–29 We now show that PECs exposed to hyperoxia exhibit increased Drp-1 activation, 
decreased mfn1 expression, and enhanced mt-fragmentation. Hyperoxia-enhanced mito-SOX 
fluorescence is blocked by mito-TEMPOL, as is enhanced mt-fragmentation. These data connect mtROS 
to enhanced mt-fragmentation and other downstream changes. There is precedent for fragmentation 
of endothelial cell mitochondria with increased ROS stress in hyperglycemia, which is also linked to 
vascular dysfunction via mitochondrial fragmentation. Mitochondrial fission is observed along with 
increased ROS production and endothelial cell apoptosis under diabetic conditions.30,31 
Mitochondrial networks are dynamic in healthy cells, shifting between a fragmented and 
tubular continuum by active fusion and division (fission).5,6,8,9 Activation of Drp-1 in pulmonary vascular 
smooth muscle cells is associated with enhanced mitochondrial fragmentation in experimental animal 
models and in samples from patients with idiopathic pulmonary arterial hypertension or diabetes 
mellitus.5,32,33 Increases in mitochondrial fragmentation and shift in proteins controlling mitochondrial 
dynamics in smooth muscle cells are linked to a proproliferative state in pulmonary artery 
hypertension. Our observation that mt-TEMPOL improves cell survival and decreases mt-fragmentation 
in PECs suggests that interventions which decrease mt-fragmentation in PECs exposed to hyperoxia 
could be protective to lung function. This interpretation is supported by improved MTT incorporation 
in hyperoxic cells treated with the Drp-1 inhibitor mDIVI or siRNA to Drp-1 (Figure 8A). 
Mfn1 and Mfn2 (mitofusion protein 2) are dynamin-related GTPases,34–36 which promote 
mitochondrial fusion. OPA-1 is a dynamin-related GTPase, which mediates fusion of inner 
mitochondrial membranes in mammalian cells.34,36 Our data show decreases in Mfn1 but increases in 
OPA-1 expression in hyperoxia-exposed PECs in culture. Decreases in Mfn1 should shift the balance of 
fusion/fission to more fission. Ryan and Archer32 identified decreased expression of Mfn2 in pulmonary 
vascular smooth muscle cells from humans and rodents with pulmonary artery hypertension. Wang et 
al37 observed that elongated mitochondria were more resistant to ROS-induced damage and 
mitophagy compared with fragmented mitochondria, supporting the position that mitochondrial 
morphology has an important role in regulating ROS and cell survival. Increases in OPA-1 would 
counter increased mitochondrial fragmentation and, thus, may represent a compensatory mechanism 
of cells stressed by hyperoxia. Genetic manipulation of Drp-1 expression in PECs support a role for at 
least this protein in cell survival and TEER in hyperoxic cells. 
Mitochondria can be marked for degradation through autophagy, which is an important 
mechanism to recover from injury. However, impaired mitophagy is observed in vascular injury 
secondary to oxidative stress5,32,38 and is believed to be central to the pro-proliferative state of 
pulmonary vascular smooth muscle cells in human pulmonary hypertension. Sequestosome-1 or 
ubiquitin-binding protein p62 can directly interact with poly- and mono-ubiquitin and LC3.39 p62 is 
recruited to ubiquitinated mitochondria,39–41 and LC3 subfamily proteins participate in 
autophagosomal membrane elongation.42 A subset of outer mitochondrial membrane proteins 
including mfn-1 and -2 are ubiquitinated in a Parkin-dependent manner.35,40 p62 can be recruited to 
the ubiquitinated mitochondria in Parkin-positive cells.39–41 PINK1 kinase activity is needed for efficient 
Parkin recruitment to impaired mitochondria.40 It is postulated to protect cells from stress-induced 
mitochondrial dysfunction by inducing autophagy. Our data support an increase in p62 and LC3B, but 
diminished PINK-1 in PECs exposed to hyperoxia in culture. p62 is also increased in whole lung 
homogenates of rats exposed in vivo to hyperoxia, suggesting activation of autophagy in vivo, as well 
as in cultured cells. A decrease in PINK-1 in hyperoxic PECs raises the possibility of inefficient 
autophagy under this condition and has been reported with increases in Drp-1 activation or decreases 
in Mfn-111. The fact that the autophagy inhibitor bafilomycin does not improve MTT incorporation in 
hyperoxia suggests that autophagy is either not involved in hyperoxic injury or it is dysfunctional, as it 
is in diseases such as aging, ischemia-reperfusion, or pulmonary hypertension.38 Definitive studies to 
evaluate autophagy flux43 and its relationship to mt-fragmentation in hyperoxia are needed. 
Cytosolic, surface, endoplasmic reticulum, and mitochondrially targeted roGFP recombinant 
viral constructs have been successfully used to identify oxidoreductive states in subcellular locations, 
including in lung cells.44 Our data demonstrate mitochondrial oxidation of cells maintained in hyperoxia 
for 48 hours in a manner that is partially reversible after 24 hours return to normoxia and is prevented 
by mito-TEMPOL. These data are consistent with our observations of increased oxidation of rat lungs 
exposed in vivo to hyperoxia.45 Our data in intact PECs are consistent with these observations and to 
our knowledge are the first to show hyperoxia-induced oxidative shifts in PECs with mt-fragmentation. 
Supporting oxidative injury and failed reparative mechanisms, we observed loss of mitochondrial 
membrane potential (Figure 3F). 
We also observe degraded function of hyperoxic-exposed cells that correlate to structural 
changes, including diminished survival, diminished transwell resistance, transwell migration, scratch 
healing, and tube formation. Migration, wound healing, and tube formation are necessary for 
resolution of lung injury. Transwell migration of endothelial cells tests the response of endothelial cells 
to invade nonperfused tissue in response to angiogenic factors, and the scratch test identifies the 
capacity of endothelium to recover a denuded (gap) area. Tubulogenesis in a 3-dimensional matrix 
mimics some of the steps in angiogenic remodeling causing alignment of endothelial cells into 
networks. Tube formation is diminished by 3 days of hyperoxia in murine fetal lung endothelial cells in 
a VEGF (vascular endothelial cell growth factor) and hepatocyte growth factor–dependent 
manner.46 Our study also documents diminished network formation, which was partially reversible by 
mito-TEMPOL. In contrast, Pendyala et al24 reported enhanced wound healing and tube formation in 
human pulmonary artery endothelial cells after 16 hours of exposure to hyperoxia relative to 
normoxia, raising the possibility of differences in functional effects based on time after hyperoxia. Our 
observations of diminished wound healing and transwell migration of PECs after 48 hours hyperoxia in 
a manner which is reversed by mito-TEMPOL is consistent with diminished cell survival and 
mitochondrial fragmentation in this time frame and in our injury model. Together, these data suggest 
that mitochondrial fragmentation correlates to degraded reparative function in cultured PECs. 
Despite hyperoxia-evoked decreases in PEC function, data support maintained viability of these 
cells. NO synthesis was significantly increased by hyperoxia, consistent with enhanced expression of 
eNOS and iNOS (inducible nitric oxide synthase), as well as cyclic GMP activity in rat pups exposed in 
vivo to hyperoxia.47 Our cultured PECs also exhibit increased eNOS expression consistent with 
enhanced NO synthesis. Changes in all end points we tested were largely reversible after 24 hours 
return to normoxia. Limited increases in LDH and apoptosis (similar scale to what we reported in 
vivo48), as well as reversibility and increased NO support hyperoxia-linked mitochondrial dysfunction 
that occurs in a setting not characterized by large-scale cell death. Of interest, mtDNA injury does not 
appear to be related to NO synthesis, as ENDO III does not protect from this end point, whereas the 
Drp-1 inhibitor mDIVI does stop hyperoxia-evoked increases in NO. 
In conclusion, we have observed hyperoxia-induced mitochondrial fragmentation and 
diminished survival in PECs which is mechanistically linked to mitochondrial ROS and mt-DNA damage 
in that they are blocked by treatment with mito-TEMPOL or ENDO III. Increased mitochondrial 
fragmentation is associated with functional consequences, as well as shifts in mt-fission and mt-fusion 
proteins in endothelial cells exposed to hyperoxia. Genetic manipulation studies support a role for Drp-
1 overexpression on hyperoxic injury. These proteins could represent targets for therapy in patients 
requiring hyperoxia if future studies confirm their capacity to modify functional outcomes. 
Nonstandard Abbreviations and Acronyms 
Drp-1 dynamin-related protein 1 
ENDO III mt-tat-endonuclease III 
LC3B microtubule-associated protein 1A/1B-light chain 3 
mDIVI mitochondrial division mitophagy inhibitor 
MFI mitochondrial fragmentation index 
Mfn1 mitofusion protein 1 
mito-SOX mitochondrially targeted superoxide indicator 
OPA-1 optic atrophy 1 
p62 LC3 adapter–binding protein SQSTM1/p62 
PEC pulmonary endothelial cell 
PINK-1 PTEN-induced putative kinase 1 
ROS reactive oxygen species 
TEER trans-endothelial electric resistance 
TOM20 translocase of outer membrane receptor complex 
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This study quantifies for the first time mitochondrial fragmentation in pulmonary endothelial cells 
exposed to hyperoxia. 
We demonstrate altered expression of several pro-fission/fusion proteins in hyperoxia and link 
enhanced expression of Drp-1 (dynamin-related protein 1) to increased mitochondrial 
fragmentation, to pulmonary endothelial cell survival, and to monolayer integrity using gene 
silencing and overexpression techniques. 
Hyperoxia-associated mitochondrial fragmentation is prevented by mito-TEMPOL and the 
mitochondrial endonuclease ENDO III (mt-tat-endonuclease III), linking this structural change to 
mitochondrial reactive oxygen species and mitochondrial DNA damage. 
Mitochondrial fragmentation in hyperoxia is observed with mitochondrial depolarization and an 
increase in pulmonary endothelial cell oxidation. 
The above changes after 48 hour hyperoxia are reversible within 24 hours return to normoxia. 
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